Page last updated: 2024-11-11

ligustilide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ligustilide: found in Umbelliferae plants; RN given refers to cpd without isomeric designation; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5319022
CHEMBL ID481246
CHEBI ID68232
SCHEMBL ID11967666
MeSH IDM0090102

Synonyms (47)

Synonym
(z)-ligustilide
(e)-ligustilide
trans-ligustilide
cis-ligustilide
SPECTRUM5_000551
(1e)-2-(4-chlorophenyl)-3-(4-morpholinyl)-n-[(z)-4-pyridinylmethylidene]-3-thioxo-1-propen-1-amine
ligustilide, (e)-
ligustilide
4431-01-0
C16987
CHEMBL481246 ,
chebi:68232 ,
(3z)-3-butylidene-4,5-dihydro-2-benzofuran-1-one
AKOS006276856
(3z)-3-butylidene-4,5-dihydroisobenzofuran-1-one
A826540
1(3h)-isobenzofuranone, 3-butylidene-4,5-dihydro-
81944-09-4
unii-10he68jd06
1(3h)-isobenzofuranone, 3-butylidene-4,5-dihydro-, (3z)-
10he68jd06 ,
ligustilide a
S9385
z-ligustilide
bdbm50441016
HY-N0401
CS-5299
(z)-3-butylidene-4,5-dihydroisobenzofuran-1(3h)-one
1(3h)-isobenzofuranone, 3-butylidene-4,5-dihydro-, (z)-
SCHEMBL11967666
Q-100482
AC-8049
3-butylidene-4,5-dihydrophthalide
mfcd01861511
ligustilide, >=98% (hplc)
3-butyliden-4,5-dihydro-3h-isobenzofuran-1-one
Q27136725
F30153
AS-15334
(3z)-3-butylidene-4,5-dihydro-1(3h)-isobenzofuranone
BCP09458
3-butylidene-4,5-dihydro-1(3h)-isobenzofuranone;1(3h)-isobenzofuranone,3-butylidene-4,5-dihydro-;(3z)-3-butylidene-4,5-dihydroisobenzofuran-1(3h)-one
CCG-266505
L-170
(3z)-3-butylidene-4,5-dihydro-2-benzofuran-1-one.
cis-ligustilidecis-ligustilide
ligusticide

Research Excerpts

Overview

Ligustilide (LIG) is a natural compound extracted from ligusticum chuanxiong hort and angelica sinensis (Oliv.) diels that exerts neuroprotective activity after cerebral ischemia reperfusion injury (CIRI) Ligusticae Gigantis Radix (Angelica gigas Nakai, root) is both medicinal herbs used to treat circulatory disorders.

ExcerptReferenceRelevance
"Ligustilide (LIG) is a major active ingredient in traditional Chinese medicines that is also found in plant rhizomes such as carrot, coriander, and others, and it has been demonstrated to have cardiovascular preventive benefits. "( A network pharmacology technique used to investigate the potential mechanism of Ligustilide's effect on atherosclerosis.
Fang, Z; Gao, J; Ji, Y; Luo, Z; Yang, R; Zhang, N, 2022
)
2.39
"Ligustilide (LIG) is a natural compound extracted from ligusticum chuanxiong hort and angelica sinensis (Oliv.) diels that exerts neuroprotective activity after cerebral ischemia reperfusion injury (CIRI)."( Ligustilide ameliorates hippocampal neuronal injury after cerebral ischemia reperfusion through activating PINK1/Parkin-dependent mitophagy.
Liu, J; Mao, Z; Seto, S; Tian, L; Wang, G; Wang, N; Wang, Y; Wu, Q, 2022
)
2.89
"Z-ligustilide is a natural benzoquinone derivative found in many widely used Chinese herbal medicines such as Angelica sinensis (Oliv.) Diels as well as Ligusticum chuanxiong Hort and so on. "( Z-ligustilide: A review of its pharmacokinetics and pharmacology.
Li, X; Liao, Y; Liu, K; Tang, H; Xie, L; Xie, Q; Zhang, L; Zheng, Y, 2020
)
2
"Z-ligustilide is a major compound in Radix Angelica sinensis, an herb from traditional Chinese medicine (TCM) most frequently prescribed for breast cancer."( Z-ligustilide restores tamoxifen sensitivity of ERa negative breast cancer cells by reversing MTA1/IFI16/HDACs complex mediated epigenetic repression of ERa.
Dou, G; He, H; Li, J; Li, L; Ma, H; Qi, H; Wang, C; Wu, M, 2017
)
1.73
"Ligustilide is a bioactive phthalide derivative isolated from Cnidii Rhizoma (Cnidium officinale, rhizome) and Angelicae Gigantis Radix (Angelica gigas Nakai, root) which are both medicinal herbs used to treat circulatory disorders. "( Ligustilide attenuates vascular inflammation and activates Nrf2/HO-1 induction and, NO synthesis in HUVECs.
Choi, ES; Han, BH; Jeong, DH; Kang, DG; Lee, HS; Lee, YJ; Yoon, JJ, 2018
)
3.37
"Ligustilide is a bioactive compound which might prevent cardiovascular complications such as thrombosis or atherosclerosis."( Ligustilide attenuates vascular inflammation and activates Nrf2/HO-1 induction and, NO synthesis in HUVECs.
Choi, ES; Han, BH; Jeong, DH; Kang, DG; Lee, HS; Lee, YJ; Yoon, JJ, 2018
)
2.64
"Ligustilide (LIG) is a major component of the herb Radix Angelicae Sinensis, with demonstrated anti-inflammatory effects."( The Protective Effect of Ligustilide in Osteoarthritis: An in Vitro and in Vivo Study.
Ding, X; Feng, Z; Hu, Z; Li, X; Ni, W; Wu, A; Wu, D; Xuan, J; Zheng, G, 2018
)
1.51
"Ligustilide is a bioactive phthalide that is said to have an anti-inflammatory effect and anti-apoptosis effect on various disorders."( Ligustilide alleviated IL-1β induced apoptosis and extracellular matrix degradation of nucleus pulposus cells and attenuates intervertebral disc degeneration in vivo.
Chen, J; Chen, T; Chen, Y; Lin, J; Shao, Z; Sheng, S; Wang, K; Wang, X; Xu, T; Ying, X; Zhang, Z, 2019
)
2.68
"Ligustilide (LIG) is a major component of Radix Angelica Sinensis, and reportedly has neuroprotective and anti-inflammatory effects. "( Ligustilide attenuates inflammatory pain via inhibition of NFκB-mediated chemokines production in spinal astrocytes.
Cao, DL; Gao, YJ; Jiang, BC; Wu, XB; Zhao, LX, 2014
)
3.29
"Ligustilide (LIG) is a principal active ingredient of traditional Chinese medicine, Radix Angelica sinensis, which has versatile pharmacological activities including neuroprotection. "( Ligustilide prevents cognitive impairment and attenuates neurotoxicity in D-galactose induced aging mice brain.
Feng, ZB; Li, JJ; Lu, YP; Qian, ZM; Zhao, P; Zhu, L; Zhu, Q, 2015
)
3.3
"Ligustilide is a major component of Radix Angelica Sinensis and reported to have anti-inflammatory and anti-nociceptive effects. "( Ligustilide Ameliorates Inflammatory Pain and Inhibits TLR4 Upregulation in Spinal Astrocytes Following Complete Freund's Adjuvant Peripheral Injection.
Dong, YL; Gao, YJ; Li, F; Qian, B; Zhang, ZJ; Zhao, LX, 2016
)
3.32
"Z-Ligustilide (Z-LIG) is a major component in Rhizoma Chuanxiong, which has been traditionally used as a health food supplement for the prevention of cerebrovascular disease in China. "( Intranasal Pretreatment with Z-Ligustilide, the Main Volatile Component of Rhizoma Chuanxiong, Confers Prophylaxis against Cerebral Ischemia via Nrf2 and HSP70 Signaling Pathways.
Li, J; Li, L; Ma, H; Qi, HY; Wu, MX; Yang, N; Yu, J; Zhao, ZL; Zheng, DD, 2017
)
1.46
"(Z)-Ligustilide [1] is a dihydrophthalide purported to be the active ingredient of Ligusticum plant species widely used as herbal medicines in the Orient and in Native American and Hispanic cultures. "( Addition of methyl thioglycolate and benzylamine to (Z)-ligustilide, a bioactive unsaturated lactone constituent of several herbal medicines. An improved synthesis of (Z)-ligustilide.
Beck, JJ; Stermitz, FR, 1995
)
1.1

Effects

Ligustilide (LIG) has potent anti-inflammatory effects, which were shown to be closely related to its neuroprotective effects against ischemic brain injury. Z-LigUSTilide has been found to be an important active component in the TCM essential oil and may serve as a candidate for the treatment of IBD.

ExcerptReferenceRelevance
"Ligustilide has promising activities and may serve as a candidate for the treatment of IBD."( Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARγ-mediated inflammation pathways.
Fang, J; Fang, S; Huang, Y; Li, M; Luo, Y; Mei, Y; Pan, H; Wan, T; Wang, Q; Wang, Z; Xue, J; Zhang, Y, 2021
)
1.61
"Ligustilide (LIG) has potent anti-inflammatory effects, which were shown to be closely related to its neuroprotective effects against ischemic brain injury."( The neuroprotective effects and probable mechanisms of Ligustilide and its degradative products on intracerebral hemorrhage in mice.
Du, JR; Han, L; He, Q; Kuang, X; Liu, DL; Shi, MQ; Zeng, QK; Zhao, LX, 2018
)
1.45
"Ligustilide has been reported to markedly protect neural tissue against apoptosis."( Ligustilide prevents the apoptosis effects of tumour necrosis factor-alpha during C2C12 cell differentiation.
Diao, J; Li, C; Lu, L; Shi, Y; Wang, D; Wang, M; Wang, Y; Wei, L; Yin, Y, 2014
)
2.57
"Z-Ligustilide has been found to be an important active component in the TCM essential oil."( Fast determination of Z-ligustilide in plasma by gas chromatography/mass spectrometry following headspace single-drop microextraction.
Deng, C; Dong, L; Shen, X; Wang, B, 2007
)
1.2

Treatment

ExcerptReferenceRelevance
"Ligustilide treatment (10 and 40 mg/kg for 8 weeks, intragastrically) in 10-month-old SAMP8 mice reduced memory deficits, amyloid-β(1)-42 accumulation, tau phosphorylation, and neuron loss, increased mitochondrial manganese-superoxide dismutase and catalase expression and activity, and decreased malondialdehyde, protein carbonyl, and 8-hydroxydesoxyguanosine levels in the brain."( Klotho upregulation contributes to the neuroprotection of ligustilide in an Alzheimer's disease mouse model.
Chen, C; Chen, YS; Du, JR; He, Q; Kuang, X; Li, LJ; Li, YJ; Liu, K; Wang, LF; Wang, Y; Zhang, MX, 2014
)
1.37

Toxicity

ExcerptReferenceRelevance
"These experimental results indicate that short term application of EO is probably safe within the range of its clinical doses, but the dose should be controlled for external use due to its slight skin irritation."( Analysis of the chemical composition, acute toxicity and skin sensitivity of essential oil from rhizomes of Ligusticum chuanxiong.
Han, T; Jiang, YP; Peng, C; Qin, LP; Ran, X; Yu, CH; Zhang, H, 2012
)
0.38
" Mechanistically, Z-ligustilide offset the adverse effects of HG/P on the activation of the AMPK/GSK-3β/Nrf2 pathway."( Alleviation of glucolipotoxicity-incurred cardiomyocyte dysfunction by Z-ligustilide involves in the suppression of oxidative insult, inflammation and fibrosis.
Cao, Y; Dong, Z; Ma, X; Wang, X; Yang, D, 2021
)
1.18

Pharmacokinetics

ExcerptReferenceRelevance
" Pharmacokinetic studies have shown that Z-ligustilide has poor oral bioavailability in rats due to severe first-pass metabolic reactions."( Z-ligustilide: A review of its pharmacokinetics and pharmacology.
Li, X; Liao, Y; Liu, K; Tang, H; Xie, L; Xie, Q; Zhang, L; Zheng, Y, 2020
)
1.54

Compound-Compound Interactions

ExcerptReferenceRelevance
" Their second derivative spectra amplified the differences and revealed the potentially characteristic IR absorption bands and combined with the correlation coefficient, concluding that 50% ethanol eluate had more ligustilide than other eluates."( Analysis of Chuanxiong Rhizoma and its active components by Fourier transform infrared spectroscopy combined with two-dimensional correlation infrared spectroscopy.
Guo, Y; Liu, Y; Lu, L; Lv, B; Meng, Q; Qu, L; Sun, S; Wang, J; Xiang, L; Xiao, Y; Yang, Y, 2016
)
0.62
" Upon metabolite identification and profiling, the incubation samples were analyzed by ultra-high-performance liquid chromatography combined with diode array detector and high-resolution mass spectrometry."( Metabolic profiling of ligustilide and identification of the metabolite in rat and human hepatocytes by liquid chromatography combined with high-resolution mass spectrometry.
Li, H; Liu, J; Tao, S, 2020
)
0.87

Bioavailability

Z-ligustilide has poor oral bioavailability in rats due to severe first-pass metabolic reactions. The inclusion complex of LIG with hydroxypropyl- β-cyclodextrin (HP-β-CD) was prepared by the kneading method.

ExcerptReferenceRelevance
" Oral bioavailability of ligustilide was low (2."( Pharmacokinetics and metabolism of ligustilide, a major bioactive component in Rhizoma Chuanxiong, in the rat.
Ko, NL; Li, SL; Lin, G; Tam, YK; Yan, R, 2008
)
0.93
" The absorption rate constants (Ka) or apparent permeability coefficients (Papp) of SMESC showed duodenum > jejunum > colon = ileum."( [In situ absorption of self-microemulsifying soft capsule of volatile oil from rhizome of ligusticum chuanxiong in rats' intestine].
Cai, Q; Huang, YP; Li, Y, 2009
)
0.35
" Pharmacokinetics and bioavailability of LIG were determined by systematic investigation in Sprague-Dawley rats."( HPLC method with fluorescence detection for the determination of ligustilide in rat plasma and its pharmacokinetics.
Qiao, H; Shi, YB; Zhang, XY, 2014
)
0.64
" The absolute bioavailability values were 71."( HPLC method with fluorescence detection for the determination of ligustilide in rat plasma and its pharmacokinetics.
Qiao, H; Shi, YB; Zhang, XY, 2014
)
0.64
"To improve the stability and oral bioavailability of Z-ligustilide (LIG), the inclusion complex of LIG with hydroxypropyl- β-cyclodextrin (HP-β-CD) was prepared by the kneading method and characterized by UV-Vis spectroscopy, differential thermal analysis (DTA) and Fourier transform infrared (FTIR) spectroscopy."( Complexation of Z-ligustilide with hydroxypropyl-β-cyclodextrin to improve stability and oral bioavailability.
Liu, S; Lu, Y; Yu, S; Zhao, Y; Zhu, L, 2014
)
0.98
" Pharmacokinetic studies have shown that Z-ligustilide has poor oral bioavailability in rats due to severe first-pass metabolic reactions."( Z-ligustilide: A review of its pharmacokinetics and pharmacology.
Li, X; Liao, Y; Liu, K; Tang, H; Xie, L; Xie, Q; Zhang, L; Zheng, Y, 2020
)
1.54

Dosage Studied

High-performance liquid chromatography with diode array detection was used to analyze the metabolites in the urine, feces, and bile of rats dosed with the essential oil. clearance (CL) of ligustilide after Chuanxiong extract administration was significantly higher than that dosed in its pure form.

ExcerptRelevanceReference
" clearance (CL) of ligustilide after Chuanxiong extract administration was significantly higher than that dosed in its pure form [CL, 20."( Pharmacokinetics and metabolism of ligustilide, a major bioactive component in Rhizoma Chuanxiong, in the rat.
Ko, NL; Li, SL; Lin, G; Tam, YK; Yan, R, 2008
)
0.95
" High-performance liquid chromatography with diode array detection was used to analyze the metabolites in the urine, feces, and bile of rats dosed with the essential oil or ligustilide."( Identification and comparison of metabolites after oral administration of essential oil of Ligusticum chuanxiong or its major constituent ligustilide in rats.
Ding, C; Du, G; Sheng, Y; Zhang, J; Zhang, Y, 2008
)
0.74
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
butenolideA gamma-lactone that consists of a 2-furanone skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)44.00000.00033.166210.0000AID772959
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (17)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (50)

Assay IDTitleYearJournalArticle
AID592254Antihyperglycemic activity in ICR mouse assessed as change in blood glucose level at 20 mg/kg after 2 hrs by oral glucose tolerance test (RVb= -12 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID592246Antidiabetic activity in streptozotocin-induced diabetic ICR mouse assessed as insulin mediated decrease in blood glucose levels by oral glucose tolerance test2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID1090239Insecticidal activity against 5 to 7 days old adult Drosophila melanogaster assessed as mortality measured as inability to move compound treated in diet at 25 degC and >90% RH treated for 8 days2005Journal of agricultural and food chemistry, Jul-13, Volume: 53, Issue:14
Larvicidal and adulticidal activity of alkylphthalide derivatives from rhizome of Cnidium officinale against Drosophila melanogaster.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1090241Insecticidal activity against Drosophila melanogaster larvae assessed as mortality compound treated in diet at 25 degC and >90% RH treated for 8 days2005Journal of agricultural and food chemistry, Jul-13, Volume: 53, Issue:14
Larvicidal and adulticidal activity of alkylphthalide derivatives from rhizome of Cnidium officinale against Drosophila melanogaster.
AID1080489Antifungal activity against Colletotrichum fragariae assessed as inhibition of fungal growth at 8 uL from 20 mg/mL compound stock solution by direct bio-autography assay2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID592330Antidiabetic activity in streptozotocin-induced diabetic ICR mouse assessed as change in blood glucose level at 56.2 mg/kg after 0.5 hr by oral glucose tolerance test (RVb= 51.9 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID592336Antidiabetic activity in streptozotocin-induced diabetic ICR mouse assessed as change in blood glucose level at 56.2 mg/kg after 1.5 hrs by oral glucose tolerance test (RVb= 0.005 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID592333Antidiabetic activity in streptozotocin-induced diabetic ICR mouse assessed as change in blood glucose level at 56.2 mg/kg after 1 hr by oral glucose tolerance test (RVb= 10.3 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID592249Antihyperglycemic activity in ICR mouse assessed as change in blood glucose level at 10 mg/kg after 1.5 hrs by oral glucose tolerance test (RVb= 2.5 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID1090237Inhibition of adult Drosophila melanogaster AChE by colorimetric method2005Journal of agricultural and food chemistry, Jul-13, Volume: 53, Issue:14
Larvicidal and adulticidal activity of alkylphthalide derivatives from rhizome of Cnidium officinale against Drosophila melanogaster.
AID1080488Antifungal activity against Colletotrichum gloeosporioides assessed as inhibition of fungal growth at 4 uL from 20 mg/mL compound stock solution by direct bio-autography assay2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID362799Chemical stability in CDCl3 after 46 days by qHNMR experiment2008Journal of natural products, Sep, Volume: 71, Issue:9
Dynamic nature of the ligustilide complex.
AID1080491Antifungal activity against Colletotrichum acutatum assessed as inhibition of fungal growth at 8 uL from 20 mg/mL compound stock solution by direct bio-autography assay2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID592332Antidiabetic activity in streptozotocin-induced diabetic ICR mouse assessed as change in blood glucose level at 31.2 mg/kg after 1 hr by oral glucose tolerance test (RVb= 10.3 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID1080492Antifungal activity against Colletotrichum acutatum assessed as inhibition of fungal growth at 4 uL from 20 mg/mL compound stock solution by direct bio-autography assay2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID1082322Adulticidal activity against female Bemisia tabaci biotype Q (sweet potato whitefly) in cucumber leaves assessed as residual contact toxicity treated for 30 secs before adult insect infestation measured after 24 hr by leaf dip bioassay2011Journal of agricultural and food chemistry, Aug-10, Volume: 59, Issue:15
Adulticidal activity of phthalides identified in Cnidium officinale rhizome to B- and Q-biotypes of Bemisia tabaci.
AID592338Antidiabetic activity in streptozotocin-induced diabetic ICR mouse assessed as change in blood glucose level at 31.2 mg/kg after 2 hrs by oral glucose tolerance test (RVb= -12.9 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID592250Antihyperglycemic activity in ICR mouse assessed as change in blood glucose level at 10 mg/kg after 2 hrs by oral glucose tolerance test (RVb= -12 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID592248Antihyperglycemic activity in ICR mouse assessed as change in blood glucose level at 10 mg/kg after 1 hr by oral glucose tolerance test (RVb= 1.5 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID772959Agonist activity at TRPA1 (unknown origin)2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
3-Ylidenephthalides as a new class of transient receptor potential channel TRPA1 and TRPM8 modulators.
AID592328Antidiabetic activity in streptozotocin-induced diabetic ICR mouse assessed as change in blood glucose level at 10 mg/kg after 0.5 hr by oral glucose tolerance test (RVb= 51.9 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID592251Antihyperglycemic activity in ICR mouse assessed as change in blood glucose level at 20 mg/kg after 0.5 hr by oral glucose tolerance test (RVb= 59 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID1080481Feeding deterrent activity against Aedes aegypti liverpool assessed as proportion of mosquitoes not biting at 25 nmol/cm2 cloth relative to untreated control2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID362797Chemical stability in MeOH after 41 days2008Journal of natural products, Sep, Volume: 71, Issue:9
Dynamic nature of the ligustilide complex.
AID592334Antidiabetic activity in streptozotocin-induced diabetic ICR mouse assessed as change in blood glucose level at 10 mg/kg after 1.5 hrs by oral glucose tolerance test (RVb= 0.005 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID592335Antidiabetic activity in streptozotocin-induced diabetic ICR mouse assessed as change in blood glucose level at 31.2 mg/kg after 1.5 hrs by oral glucose tolerance test (RVb= 0.005 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID380793Displacement of [3H]LSD from human recombinant 5HT7 receptor expressed in CHO cells at 100 uM by liquid scintillation counting relative to control2006Journal of natural products, Apr, Volume: 69, Issue:4
Serotonergic activity-guided phytochemical investigation of the roots of Angelica sinensis.
AID592247Antihyperglycemic activity in ICR mouse assessed as change in blood glucose level at 10 mg/kg after 0.5 hr by oral glucose tolerance test (RVb= 59 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID592252Antihyperglycemic activity in ICR mouse assessed as change in blood glucose level at 20 mg/kg after 1 hr by oral glucose tolerance test (RVb= 1.5 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID592253Antihyperglycemic activity in ICR mouse assessed as change in blood glucose level at 20 mg/kg after 1.5 hrs by oral glucose tolerance test (RVb= 2.5 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID1090240Relative toxicity, LC50 for rotenone Drosophila melanogaster larvicidal activity to LC50 for compound Drosophila melanogaster larvicidal activity2005Journal of agricultural and food chemistry, Jul-13, Volume: 53, Issue:14
Larvicidal and adulticidal activity of alkylphthalide derivatives from rhizome of Cnidium officinale against Drosophila melanogaster.
AID1080487Antifungal activity against Colletotrichum gloeosporioides assessed as inhibition of fungal growth at 8 uL from 20 mg/mL compound stock solution by direct bio-autography assay2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID592339Antidiabetic activity in streptozotocin-induced diabetic ICR mouse assessed as change in blood glucose level at 56.2 mg/kg after 2 hrs by oral glucose tolerance test (RVb= -12.9 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID592329Antidiabetic activity in streptozotocin-induced diabetic ICR mouse assessed as change in blood glucose level at 31.2 mg/kg after 0.5 hr by oral glucose tolerance test (RVb= 51.9 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1080490Antifungal activity against Colletotrichum fragariae assessed as inhibition of fungal growth at 4 uL from 20 mg/mL compound stock solution by direct bio-autography assay2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID1080480Feeding deterrent activity against Anopheles stephensi assessed as proportion of mosquitoes not biting at 25 nmol/cm2 cloth relative to untreated control2009Journal of agricultural and food chemistry, Jan-28, Volume: 57, Issue:2
Bioactivity-guided fractionation and GC/MS fingerprinting of Angelica sinensis and Angelica archangelica root components for antifungal and mosquito deterrent activity.
AID362795Chemical stability in heaxane; EtOAc:MeOH:H2O-7 (9:1:9:1) after 41 days by qHNMR experiment2008Journal of natural products, Sep, Volume: 71, Issue:9
Dynamic nature of the ligustilide complex.
AID1082321Biotype susceptibility ratio, ratio of LC50 for female adult Bemisia tabaci biotype Q (sweet potato whitefly) to LC50 for female adult Bemisia tabaci biotype B2011Journal of agricultural and food chemistry, Aug-10, Volume: 59, Issue:15
Adulticidal activity of phthalides identified in Cnidium officinale rhizome to B- and Q-biotypes of Bemisia tabaci.
AID1082320Adulticidal activity against female Bemisia tabaci biotype B (sweet potato whitefly) in cucumber leaves assessed as residual contact toxicity treated for 30 secs before adult insect infestation measured after 24 hr by leaf dip bioassay2011Journal of agricultural and food chemistry, Aug-10, Volume: 59, Issue:15
Adulticidal activity of phthalides identified in Cnidium officinale rhizome to B- and Q-biotypes of Bemisia tabaci.
AID1090238Relative toxicity, LD50 for rotenone Drosophila melanogaster adulticidal activity to LD50 for compound Drosophila melanogaster adulticidal activity2005Journal of agricultural and food chemistry, Jul-13, Volume: 53, Issue:14
Larvicidal and adulticidal activity of alkylphthalide derivatives from rhizome of Cnidium officinale against Drosophila melanogaster.
AID592240Inhibition of yeast alpha-glucosidase assessed as inhibition of p-nitrophenyl-alpha-D-glucopyranoside substrate hydrolysis after 35 mins by spectroscopy2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID382168Induction of proliferation of rat mesenchymal stem cells by MTT assay2008Bioorganic & medicinal chemistry, May-01, Volume: 16, Issue:9
Characterization of chemical components in extracts from Si-wu decoction with proliferation-promoting effects on rat mesenchymal stem cells.
AID592337Antidiabetic activity in streptozotocin-induced diabetic ICR mouse assessed as change in blood glucose level at 10 mg/kg after 2 hrs by oral glucose tolerance test (RVb= -12.9 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID362798Chemical stability in CDCl3 after 46 days by GC-MS analysis2008Journal of natural products, Sep, Volume: 71, Issue:9
Dynamic nature of the ligustilide complex.
AID592331Antidiabetic activity in streptozotocin-induced diabetic ICR mouse assessed as change in blood glucose level at 10 mg/kg after 1 hr by oral glucose tolerance test (RVb= 10.3 %)2011Journal of natural products, Mar-25, Volume: 74, Issue:3
(Z)-3-butylidenephthalide from Ligusticum porteri , an α-glucosidase inhibitor.
AID362796Chemical stability in DMSO after 41 days2008Journal of natural products, Sep, Volume: 71, Issue:9
Dynamic nature of the ligustilide complex.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (218)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (1.83)18.7374
1990's9 (4.13)18.2507
2000's50 (22.94)29.6817
2010's118 (54.13)24.3611
2020's37 (16.97)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.24

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.24 (24.57)
Research Supply Index5.41 (2.92)
Research Growth Index5.41 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.24)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (2.24%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other218 (97.76%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]